๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

p53 gene mutations and 17p allelic deletions in hepatocellular Carcinoma from Japan

โœ Scribed by Haruhiko Nose; Fumio Imazeki; Masao Ohto; Masao Omata

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
590 KB
Volume
72
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

p53 MUTATION, ALLELE LOSS ON CHROMOSOME
p53 MUTATION, ALLELE LOSS ON CHROMOSOME 17p, AND DNA CONTENT IN OVARIAN CARCINOMA
โœ McMANUS, D. T.; MURPHY, M.; ARTHUR, K.; HAMILTON, P. W.; RUSSELL, S. E. H.; TONE ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 569 KB

The aim of this investigation was to explore the relationships between pS3 mutation, DNA aneuploidy, 17p deletions, and clinical stage in ovarian cancer. Nuclear suspensions were obtained by tissue disaggregation, stained with propidium iodide, and analysed on a Coulter EPICS Elite flow cytometer. D

P53 tumor suppressor gene mutations in h
P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India
โœ Sanjay Katiyar; Bipin C. Dash; Varsha Thakur; Raj C. Guptan; Shiv K. Sarin; Bhud ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 158 KB ๐Ÿ‘ 3 views

BACKGROUND. Specific mutations of the p53 tumor suppressor gene in hepatocellular carcinoma (HCC) have been reported from several parts of the world, but to the authors' knowledge to date the status of this gene has not been studied in HCC patients in India, where HCC is one of the major cancers and

p53 gene mutations in oral carcinomas fr
p53 gene mutations in oral carcinomas from India
โœ Arasambattu K. Munirajan; Yuko Tutsumi-Ishii; Bagavathi K. C. Mohanprasad; Yasum ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 437 KB ๐Ÿ‘ 2 views

In this study, we analyzed 53 oral squamous-cell carcinomas among Indians for the presence of alterations in the tumorsuppressor gene p53 by PCR-SSCP and sequencing methods. Our results showed that 21% (I 1/53) of oral carcinomas analyzed carried mutations within the exons 5-8 of the p53 gene. We h

p21/WAF1, p53 and PCNA expression and p5
p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma
โœ Lan Fang Qin; Irene O. L. Ng; Sheung T. Fan; Matthew Ng ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 443 KB ๐Ÿ‘ 2 views

The cyclin-dependent kinase inhibitor p21/WAF1 is regulated by p53-dependent and p53-independent pathways. In addition, p21/WAF1 binds with proliferating cell nuclear antigen (PCNA) and inhibits the action of PCNA. To investigate the possible role of p21/WAF1 in human hepatocellular carcinomas (HCCs